3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
136
Motor Activity
72
Fatigue
10
Neoplasms
9
Obesity
8
Lymphedema
8
Colorectal Neoplasms
7
Weight Loss
6
Cardiotoxicity
6
Prostatic Neoplasms
5
Breast Cancer Lymphedema
5
Ovarian Neoplasms
3
Breast Cancer Female
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Overweight
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Insulin Resistance
2
Depression
2
Breast Diseases
2
Breast Cancer Survivors
2
Body Weight Changes
2
Atherosclerosis
2
Arthralgia
2
Ventricular Dysfunction, Left
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
Tamoxifen
21
Radiotherapy
9
Chemotherapy, Adjuvant
9
Specimen Handling
8
Early Intervention, Educational
8
Anastrozole
7
Neoadjuvant Therapy
6
Methods
6
Letrozole
6
Psychiatric Rehabilitation
5
Practice Guidelines as Topic
5
Immunohistochemistry
5
Counseling
5
Biopsy
5
Standard of Care
4
Mastectomy, Segmental
4
Mass Spectrometry
4
Magnetic Resonance Spectroscopy
4
Gene Expression Profiling
4
Educational Status
4
Behavior Therapy
4
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Brachytherapy
3
Watchful Waiting
2
Therapeutics
2
Telemedicine
2
Taxes
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Carcinoma In Situ
×
Exercise
×
Breast
×
Clear all
NCT02240836
2024-04-08
EBBA-II
Oslo University Hospital
Phase NA
Active not recruiting
545 enrolled